SCHEMBL4748482

SCHEMBL4748482

Cc1oc(-c2ccccc2)nc1CCOc1ccc(CN2CCCCC2C(=O)O)cc1

nearest known ligand 0.63

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARG P37231 19/20 0.63
PPARA Q07869 14/20 0.58
CD274 Q9NZQ7 1/20 0.57
PPARD Q03181 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4745027 1.00 PPARG (0.63) PPARGPPARACD274PPARD
SCHEMBL4748488 0.97 PPARG (0.62) PPARGPPARAPPARD
SCHEMBL4748485 0.97 PPARG (0.62) PPARGPPARAPPARD
SCHEMBL4748310 0.96 PPARG (0.60) PPARGPPARAPPARD
SCHEMBL4748313 0.96 PPARG (0.60) PPARGPPARAPPARD
SCHEMBL4862900 0.94 PPARG (0.57) PPARGPPARACD274PPARD
SCHEMBL4743784 0.92 PPARG (0.61) PPARGPPARAPPARD
SCHEMBL4743787 0.92 PPARG (0.61) PPARGPPARAPPARD
SCHEMBL4746214 0.92 CD274 (0.63) PPARGPPARACD274
SCHEMBL4746225 0.92 CD274 (0.63) PPARGPPARACD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008117982-A1 HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR INHIBITING LIPID ACCUMULATION CONTAINING SAME CRYSTAL GENOMICS, INC. (KR) 2008-10-02 WO claimed
WO-2008117982-A1 HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR INHIBITING LIPID ACCUMULATION CONTAINING SAME CRYSTAL GENOMICS, INC. (KR) 2008-10-02 WO disclosed
US-7279485-B2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method BRISTOL-MYERS SQUIBB COMPANY (US) 2007-10-09 US disclosed